NK

Narahari Kousik

Director Director DIN 02407625
DIN 02407625 First appointment Nov 2008 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Nov 2008
Shareholding value β€’β€’β€’β€’ Premium profile

About Narahari Kousik

Data last updated:

Narahari Kousik was a Director at Premas Biotech Private Limited (2008–2011) and Additional Director at Premas Life Sciences Private Limited (2011). The companies operate in Pharma and Healthcare.

DIN 02407625
Primary Designation Director
Industry Pharma
First Appointment 05 Nov 2008

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Premas Biotech Private Limited U24232HR2005PTC035932
Director05 Nov 20082005₹45.93 Cr (FY 2025)Active
Premas Life Sciences Private Limited U51909DL2011PTC217592
Additional Director16 May 20112011₹310 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Premas Biotech Private Limited
Premas Life Sciences Private Limited
Premium access

Shareholding and investment profile for Narahari Kousik

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Narahari Kousik

Narahari Kousik was first appointed on 05 Nov 2008 as Director at Premas Biotech Private Limited. The most recent appointment on record is 16 May 2011 at Premas Life Sciences Private Limited.

Narahari Kousik held 2 earlier board appointments: Premas Biotech Private Limited (Director, 05 Nov 2008 to 14 Oct 2011); Premas Life Sciences Private Limited (Additional Director, 16 May 2011 to 14 Oct 2011).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available